
Opinion|Videos|June 10, 2024
Overview of the QUILT Trial in BCG-Unresponsive NMIBC
Jason Hafron, MD, CMO, provides an overview of the QUILT trial investigating N-803 in patients with BCG-unresponsive high-grade non–muscle invasive bladder cancer.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: Cribriform Histology in Prostate Cancer, With Tyler Seibert, MD, PhD
2
CMS' 2027 PFS proposed rule: Modifier -25 cuts, G2211 overhaul loom
3
Mary Dunn, MSN, NP-C, OCN, RN, on advances reshaping advanced prostate cancer care
4
Rezūm shows greater 1-year BPH symptom relief vs pharmacotherapy
5











